The radical Left has normalized abortion so much that people only have to go to a local grocery store.
But conservatives are doing everything they can to push back against the murder of unborn children.
Now Christian investors are turning up the heat on retailers preparing to sell this dangerous abortion drug.
Radical abortion lobby moves to expand access to dangerous abortion drugs
In 2022, Roe v. Wade was overturned by the Supreme Court and a nationwide battle unfolded.
Pro-life lawmakers saw the opportunity to begin protecting the unborn after decades of death.
Abortion on-demand Democrat activists began working on constitutional amendments to guarantee their anti-life agenda.
And the Biden-Harris regime started working on ways to increase access to chemical abortion drugs.
In 2023, the Food and Drug Administration (FDA) loosened restrictions on the drugs to allow pharmacies to dispense, and in some circumstances prescribe, mifepristone to women seeking abortions.
The drug is the first step in the disgusting chemical abortion process.
Now, major retailers are under pressure to begin furnishing the drugs.
But Robert Netzly, the CEO of Inspire Investing, is leading a group of Christian investors to push back on the deadly new initiative.
Investors tell major retailers to consider the “legality” of abortion drugs
Netzly recently authored open letters along with other Christian investors telling leadership at Walmart, Costco, Kroger, and more that it’s not too late to make the right choice.
The letter recognized pressure by the New York City Comptroller to “immediately take the necessary steps” to dispense mifepristone at their stores.
The Christian investors say that the so-called “growing market opportunity” and the need to avoid “repetitional risks” was ill-advised.
And that there might be more to lose if these retailers don’t recognize the safety risks to consumers and the potential liabilities to their brands.
“Maximizing shareholder value requires [brands] to avoid politicizing its services and to continue to do what [they] have always done best, provide excellent grocery and retail goods to families,” they wrote.
The investors said that the “legality of dispensing and distributing the abortion drug is in flux” and warned that they could see legal repercussions if they don’t suspend the plan.
But the real weight of the risk isn’t just found in the legal system.
The financial risk to selling mifepristone should not be ignored
Combined, the investors own over $1 billion in stock, and they are prepared to show their interests.
Each letter made it clear that the brands could lose their support if they continue to put investor money at risk.
“We write to urge [brands], for [their] own sake and the sake of. . .shareholders and customers, to continue. . .current practices of not dispensing the abortion drug mifepristone,” the letter said.
The investors warned that the retailers risked “alienating” customers “just to boost one product” in their pharmacies.
In the Costco letter, they cited over “6,000 members [that] have already signed a petition asking [them] not to sell mifepristone.”
The letter accused Costco of directly “shrinking [their] customer base.”
The investors cited statistics by the Brookings Institute that show the average American family will spend over $300,000 to raise each child including food, clothing, furniture, and other household needs.
“Dispensing the abortion drug will reduce demand for all of these and only make worse the crisis of record low birth rates,” they said.
US Political Daily will keep you updated on any developments to this ongoing story.
